Jing Wang

Dr. Jing Wang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2023 in Spine
Verified
Journal Article
Open access
YYYuan Mm Yan
Yuan Mm Yan
GZGuoqing Zhong
Guoqing Zhong
HLHuahao Lai
Huahao Lai
CHChongquan Huang
Chongquan Huang
MYMnegyu Yao
Mnegyu Yao
YZYu Zhang
Yu Zhang
Study Design.: Retrospective case series. Objective.: To investigate the accuracy of seven scoring systems for the prediction of survival in lung cancer patients with spinal metastases (SPM). Summary of Background Data.: Although survival scoring systems have been developed for surgical decision-making, the reliability and validity of these models are unclear for specific cancer types. As the prevalence of patients with lung cancer increases, it is imperative to determine the accuracy of these models for lung cancer patients with SPM. Materials and Methods.: This is a retrospective study of a cohort of lung cancer patients with SPM who underwent spine surgery between 2019 and 2021 at two centers. The optimal area under the curve (AUC) was calculated to evaluate the accuracy of seven candidate scoring systems at 3, 6, and 12 months. Calibration and decision curve analysis was used for further validation. Results.: A total of 166 patients (mean age: 58.98±10.94; 105 males and 61 females) with SPM were included. The median postoperative survival was 12.87±0.93 months. The modified Bauer score, revised Tokuhashi score, Linden score, Tomita score, the Skeletal Oncology Research Group nomogram, and the New England Spinal Metastasis Score in prediction survival at 3, 6, and 12 months showed a slightly weaker AUC (range 0.464–0.659). The AUC of the Katagiri-New score in predicting 1-year survival for lung cancer patients was the highest (0.708; range 0.619–0.798). The decision curve analysis showed that the Katagiri-New score led to a greater net benefit than the strategies of changing management for all patients or none of the patients. Conclusions.: This study suggests that the most commonly used models have limitations in predicting survival in patients undergoing spinal surgery for metastatic lung cancer and underestimate survival. In this sample of lung cancer patients, the Katagiri-New Scoring system score had the best performance in predicting 1-year survival. Level of Evidence.: 4.

7 June 2022 in Journal of Bone Oncology
Verified
Journal Article
Open access
JCJiashi Cao
Jiashi Cao
XHXing Huang
Xing Huang
NCNa Cui
Na Cui
XWXiang Wang
Xiang Wang
CYChaoqun You
Chaoqun You
TLTielong Liu
Tielong Liu
Extra-adrenal myelolipomas (EAMs) are rare benign tumors composed of both mature adipose and hematopoietic tissues with unclear etiology. There have been only sporadic case reports about the clinical characteristics and management of EAMs. Here we present our experience and practice in the clinical diagnosis and treatment of 11 consecutive patients with EAMs. We retrospectively reviewed 11 consecutive patients, who received surgeries in our department and were confirmed as having EAMs by postoperative histopathology from April 2016 to December 2021. Clinical information and follow-up data of all patients were collected and analyzed afterwards. Of the 11 EAM patients (7 male and 4 female) with a mean age of 47.6 years, 3 were asymptomatic and 8 were symptomatic with a mean symptom duration of 6.07 months. EAMs were found in the thoracic spine in 4 cases, paravertebral mediastinal regions in 3 cases, ilium in 2 cases, humerus in 1 case, and rib in 1 case. All patients were initially misdiagnosed as other tumors by radiologists. All 11 patients received gross total excision or curettage with a mean intraoperative blood loss of 781.82 ± 1143.3 ml and a mean operation duration of 180.91 ± 98.41 min. Patients’ Frankel scores and Karnofsky Performance Status score were improved or at least preserved postoperatively. No significant complications occurred postoperatively. All the 11 patients survived, and no local recurrence or distant metastasis occurred during the mean follow-up period of 42.0 months. The surgical outcome and prognosis of EAMs are excellent and surgery can serve as the method of radical treatment.

9 June 2015 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
JWJing Wang
Jing Wang
CZChenglong Zhao
Chenglong Zhao
JCJianjun Chu
Jianjun Chu
CYCheng Yang
Cheng Yang
JKJinhai Kong
Jinhai Kong
JXJianru Xiao
Jianru Xiao

6 November 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
CYChaoqun You
Chaoqun You
JCJiashi Cao
Jiashi Cao
YDYan Du
Yan Du
CPCheng Peng
Cheng Peng
LCLinfei Cheng
Linfei Cheng
TLTielong Liu
Tielong Liu

1 January 2025 in Analytical Cellular Pathology
Verified
Journal Article
Open access
CPCheng Peng
Cheng Peng
CYChaoqun You
Chaoqun You
SCShuang Cao
Shuang Cao
LCLinfei Cheng
Linfei Cheng
JRJiaji Ren
Jiaji Ren
TLTielong Liu
Tielong Liu
Osteosarcoma (OS), characterized by a complex tumor microenvironment, poses challenges in treatment, metastasis, and therapy resistance. This study examined the impact of lactylation, a posttranslational modification, on gene expression and tumor behavior in OS, particularly its influence on prognosis, immune cell infiltration, and chemotherapy response. Utilizing data from the Gene Expression Omnibus series accession number 21257 (GSE21257) and the Therapeutically Applicable Research to Generate Effective Treatments on Osteosarcoma (TARGET‐OS) datasets, the investigation focused on analyzing the expression profiles of 267 lactylation modifier genes, which were selected from a total of 336 lactylation‐related genes compiled from various studies in the literature. The methods included unsupervised clustering using “ConsensusClusterPlus” heatmap generation with “pheatmap” pathway analysis from several databases, and immune cell infiltration assessment using the “single‐sample Gene Set Enrichment Analysis (ssGSEA)” function. The research revealed 36 significant lactylation‐related genes in OS, categorizing them into two clusters with distinct survival and biological characteristics. One cluster demonstrated poor prognosis due to increased tumor cell proliferation and specific immune cell variations, also showcasing genes that enhance tumor growth and metastasis, thus indicating its aggressive nature and adverse outcomes for patients. These insights are crucial for understanding the molecular mechanisms of OS and identifying therapeutic targets. Therefore, the study elucidates the role of lactylation‐related genes in the prognosis, pathogenesis, and treatment response of OS, laying the groundwork for further exploration into potential therapeutic targets and the underlying mechanisms within OS.

22 June 2024 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
MYMinglei Yang
Minglei Yang
NZNanzhe Zhong
Nanzhe Zhong
ZDZeyu Dai
Zeyu Dai
XMXiaoyu Ma
Xiaoyu Ma
ALAo Leng
Ao Leng
JXJianru Xiao
Jianru Xiao